Journal List > J Korean Soc Transplant > v.24(1) > 1034310

J Korean Soc Transplant. 2010 Mar;24(1):19-25. Korean.
Published online March 31, 2010.  https://doi.org/10.4285/jkstn.2010.24.1.19
Copyright © 2010 The Korean Society for Transplantation
Symptomatic Lower Extremity Deep Vein Thrombosis after Kidney Transplantation: a 40-Year Single Center Experience in Korea
Jeong Kye Hwang, M.D., Sang Dong Kim, M.D., Sun Cheol Park, Ph.D., Ji Il Kim, Ph.D., and In Sung Moon, M.D.
Department of Surgery, The Catholic University of Korea College of Medicine, Seoul, Korea.

Corresponding author (Email: cmckji@catholic.ac.kr )
Received February 06, 2010; Accepted March 08, 2010.

Abstract

Background

It is well known that kidney transplant recipients in Western countries are at high risk for development of lower extremity (LE) deep vein thrombosis (DVT). The aim of this study was to establish the frequency of symptomatic LE DVT, the time until their occurrence, and to define risk factors for them following kidney transplantation (KT) in Korea.

Methods

We performed a retrospective analysis of LE DVT among 1695 patients who were kidney transplant recipients between 1969 and 2009. All patients were symptomatic with objective diagnostic modalities. Results were compared with those for a cohort of kidney transplant recipients from the same center without DVT.

Results

During follow-up, 21 symptomatic LE DVTs (1.2%) occurred in 18 patients (1.1%). The mean interval between transplantation and a first episode of DVT was 77.1±76.6 months. No DVT episode developed within one month after KT. There were no significant differences in body mass index, graft function, donor age and sex, recipient sex, type of preoperative renal replacement therapy, immunosuppressive agents, and malignancy between the two groups. Patients who developed LE DVT had a significantly different recipient age, presence of diabetes mellitus, presence of acute rejection episodes, and type of donor (P<0.05).

Conclusions

Our retrospective study showed that the incidence of LE symptomatic DVT after KT is lower than after other surgeries performed in Korean hospitals and after KT performed in Western countries. There were no cases of symptomatic DVT within 1 month after KT. Our findings suggest that aggressive DVT prevention is not necessary for KT recipients in Korea.

Keywords: Kidney transplantation; Symptomatic deep vein thrombosis; Risk factors

Figures


Fig. 1
Time of occurrence of the first deep vein thrombosis following renal transplantation.
Click for larger image

Tables


Table 1
Characteristics of patients investigated
Click for larger image


Table 2
Treatment methods and results of deep vein thrombosis
Click for larger image


Table 3
Summary of reported series of lower extremity deep vein thrombosis in renal transplant recipients
Click for larger image

References
1. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. 8th Ed. Chest 2008;133 6S:381–453.
2. Irish AB, Green FR. Environmental and genetic determinants of the hypercoagulable state and cardiovascular disease in renal transplant recipients. Nephrol Dial Transplant 1997;12:167–173.
3. Ramirez PJ, Gohh RY, Kestin A, Monaco AP, Morrissey PE. Renal allograft loss due to proximal extension of ileofemoral deep venous thrombosis. Clin Transplant 2002;16:310–313.
4. Butt KM, Rao TK, Friedman EA, Kountz SL. Venous complications of renal transplantation. Proc Clin Dial Transplant Forum 1975;5:77–80.
5. Joffe SN. Deep vein thrombosis after renal transplantation. Vasc Surg 1976;10:134–137.
6. Venkateswara K, Smith EJ, Alexander JW, Fidler JP, Pemmaraju SR, Pollack VE. Thromboembolic disease in renal allograft recipients. What is its clinical significance? Arch Surg 1976;111:1086–1092.
7. Arnadottir M, Bergentz SE, Bergqvist D, Husberg B, Konrad P, Lindholm T. Thromboembolic complications after renal transplantation: a retrospective analysis. World J Surg 1983;7:757–761.
8. Bergqvist D, Bergentz SE, Bornmyr S, Husberg B, Konrad P, Ljungnér H. Deep vein thrombosis after renal transplantation: a prospective analysis of frequency and risk factors. Eur Surg Res 1985;17:69–74.
9. Vanrenterghem Y, Roels L, Lerut T, Gruwez J, Michielsen P, Gresele P, et al. Thromboembolic complications and haemostatic changes in cyclosporin-treated cadaveric kidney allograft recipients. Lancet 1985;1:999–1002.
10. Allen RD, Michie CA, Murie JA, Morris PJ. Deep venous thrombosis after renal transplantation. Surg Gynecol Obstet 1987;164:137–142.
11. Gruber SA, Pescovitz MD, Simmons RL, Najarian JS, Ascher NL, Payne WD, et al. Thromboembolic complications in renal allograft recipients. A report from the prospective randomized study of cyclosporine versus azathioprine-antilymphocyte globulin. Transplantation 1987;44:775–778.
12. Vachharajani TJ, Asari AJ, Tucker B, Baker LR. Ipsilateral deep venous thrombosis in renal transplant recipients: the need for prolonged anticoagulation. Nephrol Dial Transplant 1997;12:627–628.
13. Humar A, Johnson EM, Gillingham KJ, Sutherland DE, Payne WD, Dunn DL, et al. Venous thromboembolic complications after kidney and kidney-pancreas transplantation: a multivariate analysis. Transplantation 1998;65:229–234.
14. Poli D, Zanazzi M, Antonucci E, Bertoni E, Salvadori M, Abbate R, et al. Renal transplant recipients are at high risk for both symptomatic and asymptomatic deep vein thrombosis. J Thromb Haemost 2006;4:988–992.
15. Derweesh IH, Ismail HR, Goldfarb DA, Araki M, Zhou L, Modlin C, et al. Intraoperative placing of drains decreases the incidence of lymphocele and deep vein thrombosis after renal transplantation. BJU Int 2008;101:1415–1419.
16. Park WI, Hahn JS, Kim CY, Jang JH, Lee ST, Min YH, et al. Venous thrombosis after renal transplantation. Korean J Hemost Thromb 2000;7:41–46.
17. Haines ST. Venous thromboembolism: pathophysiology and clinical presentation. Am J Health Syst Pharm 2003;60:S3–S5.
18. Brunkwall J, Bergqvist D, Bergentz SE, Bornmyr S, Husberg B. Postoperative deep venous thrombosis after renal transplantation. Effects of cyclosporine. Transplantation 1987;43:647–649.
19. Joffe SN. The incidence of postoperative deep vein thrombosis. Thromb Res 1975;7:141–148.
20. Prandoni P, Lensing AW, Cogo A, Cuppini S, Villalta S, Carta M, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996;125:1–7.
21. Poli D, Zanazzi M, Antonucci E, Marcucci R, Rosati A, Bertoni E, et al. High rate of recurrence in renal transplant recipients after a first episode of venous thromboembolism. Transplantation 2005;80:789–793.
22. Von Kaulla KN, Von Kaulla E, Wasantapruck S, Marchioro TL, Starzl TE. Blood coagulation in uremic patients before and after hemodialysis and transplantation of the kidney. Arch Surg 1966;92:184–191.
23. Ljungqvist U, Bergentz SE, Leandoer L, Nilsson IM. Coagulation and fibrinolysis after renal transplantation. Scand J Urol Nephrol 1969;3:23–29.
24. Merkus JW, Barendregt WB, van Asten WN, van Langen H, Hoitsma AJ, van der Vliet JA. Changes in venous hemodynamics after renal transplantation. Transpl Int 1998;11:284–287.
25. Movat HZ, Mustard JF, Taichman NS, Uriuhara T. Platelet aggregation and release of ADP, serotonin and histamine associated with phagocytosis of antigen-antibody complexes. Proc Soc Exp Biol Med 1965;120:232–237.
26. Rosendaal FR. Risk factors for venous thrombotic disease. Thromb Haemost 1999;82:610–619.
27. Kim IG, Kim KH, Seo HJ, Kim JI, Ahn CH, Kim JS, et al. Deep vein thrombosis after surgery for gastrointestinal cancer-incidence and correlation with risk factors-. J Korean Soc Vasc Surg 2004;20:237–241.
28. Yun SS, Choi SH, Kim SD, Cho HJ, Park SC, Kim KH, et al. The risk factors for pulmonary embolism in patients with lower extremity deep vein thrombosis. J Korean Soc Vasc Surg 2008;24:119–124.
29. Hamlin CR, Kohn RR, Luschin JH. Apparent accelerated aging of human collagen in diabetes mellitus. Diabetes 1975;24:902–904.
30. Kobayashi M, Yorioka N, Yamakido M. Hypercoagulability and secondary hyperfibrinolysis may be related to abnormal lipid metabolism in patients treated with continuous ambulatory peritoneal dialysis. Nephron 1997;76:56–61.